| Today's Open | $9.68 |
|---|---|
| Previous Close | $9.60 |
| Daily Range | $9.56 - $9.92 |
| 52-Week Range | $5.65 - $11.34 |
| Market Cap | $1.1B |
| P/E Ratio | -5.93 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 1,299,016 |
| Average Daily Volume | 908,708 |
| Current FY EPS | -$1.00 |
Sector
Healthcare
Industry
Drugs
Nektar Therapeutics (NKTR) Description
A biopharmaceutical company which develops breakthrough products that make a difference in patients' lives. It creates differentiated, innovative products by applying its platform technologies to established or novel medicines. Website: http://www.nektar.com/
News & Commentary
Bayer Initiates Phase III Trial of BAY41-6551T, Delivered by a Pulmonary Drug Delivery System Develo
Bayer Initiates Phase III Trial of BAY41-6551T, Delivered by a Pulmonary Drug Delivery System Developed by Nektar Therapeutics3 Stocks to Get on Your Watchlist
An international steelmaker, a budding pharmaceutical company, and a rapidly growing tech stock are three names worth adding to your watchlist this week.Here's Why Nektar Therapeutics's Latest Report Might Worry You
Don't just ask, "How much inventory?" Ask, "What kind?"NKTR's Top Competitors
(1.98%)
(3.37%)
(0.90%)
(0.96%)